PA
EXLS icon

PharVision Advisers’s EXL Service EXLS Stock Holding History

PharVision Advisers’s Portfolio EXLS Stock Details EXLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,549
Closed -$830K – 287
2025
Q4 		$830K Buy
19,549
+1,825
+10% +$74.6K 0.42% 1
2025
Q3 		$780K Hold
17,724
– – 0.44% 2
2025
Q2 		$776K Hold
17,724
– – 1.12% 1
2025
Q1 		$837K Sell
17,724
-3,380
-16% -$163K 1.16% 1
2024
Q4 		$937K Buy
+21,104
New +$913K 0.79% 1

Other funds holding EXLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PharVision Advisers's EXLS Position: Q1 2026 in Review

PharVision Advisers sold out of EXL Service (EXLS) in Q1 2026, closing a stake of 19,549 shares — an estimated $830K sold.

PharVision Advisers first reported a position in EXLS in Q4 2024 and held it in 5 quarters. The position peaked at $937K in Q4 2024. 458 funds tracked by Wall St. Rank hold EXLS as of Q1 2026.

  • PharVision Advisers reported no remaining EXL Service position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 19,549 EXL Service shares in Q1 2026, an estimated $830K.
  • PharVision Advisers first reported a position in EXL Service in Q4 2024 and held it in 5 quarters.
  • PharVision Advisers's EXL Service position peaked at $937K in Q4 2024.
  • 458 funds tracked by Wall St. Rank held EXL Service as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.